Skip to main content
Equibles
SIBN logo

SIBN · SI-BONE, Inc. · Metrics

Track SIBN — free

Use SIBN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SIBN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.54 +0.88 (+4.48%) At close · Oct 20
Russell 2000 member Rebalance outlook locked
Market Cap
$881.13M
Shares
44.82M
Volume · Oct 20 640.82K Avg daily vol (3M) 555.57K

SIBN metrics

90 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.54
Market cap
$881.13M

Price action

20 metrics
Price change (1W)
+4.4%
Price change (30D)
+11.3%
Price change (3M)
+20.5%
Price change (6M)
+48.6%
Price change (YTD)
+4.2%
Price change (1Y)
+35.0%
Trailing year
Price change (5Y)
-9.2%
52-week high
$21.40
52-week low
$11.61
Change from 52-week high
-4.0%
Change from 52-week low
+76.9%
Annualized volatility
48.6%
Annualized volatility (3M)
35.8%
Beta
0.6
RSI (14D)
63.0
Price vs SMA 50
+7.9%
Price vs SMA 200
+25.9%
Avg volume (3M)
555,574
Relative volume
1.2
Average dollar volume
$10.44M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
44.82M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.1×
reciprocal yield 24.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.1×
reciprocal yield 24.2%
P / book
4.8
reciprocal yield 20.7%
FCF yield
-0.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
355.6
reciprocal yield 0.3%
Earnings yield
-1.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.2×
reciprocal yield 23.7%
EV / revenue historical average (5Y)
5.3×
reciprocal yield 19.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-02
Last earnings
2026-08-03

Profitability

9 metrics
Gross margin
79.5%
Operating margin
-8.3%
Trailing 12 months
Net margin
-6.9%
Gross profit (TTM)
$169.87M
Operating profit (TTM)
−$17.75M
Net income (TTM)
−$14.63M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
-2.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$4.88
Gross profit per diluted share (TTM)
$3.88
Operating profit per diluted share (TTM)
$-0.41
EBITDA per diluted share (TTM)
$-0.26
Net income per diluted share (TTM)
$-0.33
Operating cash flow per diluted share (TTM)
$0.06
Free cash flow per diluted share (TTM)
$-0.10
Capital expenditures per diluted share (TTM)
$0.16
R&D per diluted share (TTM)
$0.41
Stock compensation per diluted share (TTM)
$0.55
Book value per share
$4.07

Growth

11 metrics
Revenue growth YoY
+15.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$213.60M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+23.6%
Revenue CAGR (5Y)
+22.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-8.0%
Return on assets
-5.9%
Debt / equity
0.2
Current ratio
9.1
EBITDA (TTM)
−$11.32M
Free cash flow (TTM)
−$4.39M
Quick ratio
7.6
Interest coverage
-7.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.50M
Latest balance sheet
Cash & equivalents
$33.13M
Total assets
$248.76M
Total debt
$35.63M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.48M
Capital expenditures (TTM)
$6.87M
R&D (TTM)
$18.02M
SG&A (TTM)
—
Stock compensation (TTM)
$24.21M
R&D / revenue
8.4%
Stock compensation / revenue
11.3%

Ownership (13F)

9 metrics
13F filers
169
13F filer change QoQ
-11
Institutional ownership
106.8%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+13.9%
Holder tenure
15.7
Price vs estimated holder cost
-4.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
13.2%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 8.7 days to cover
Days to cover
8.7d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.65M
Insider-sentiment score
16 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1459839 CUSIP 825704109 13F (30d) 17 filings 17 filers Visit website Investor relations